Bioprinting in Healthcare and Therapeutic Continuity

Dear Colleagues,

3D bioprinting enables the rapid customization of personalized medical devices, drugs, and applications, achieving the ability to restore human functionalities.

This topical collection will collect articles related to the application of 3D printing/bioprinting in the medical sector, following the therapy continuity approach.

• Big data: biosensors and wearable devices or prototypes capable of collecting data and supporting the big-data chain;
• Advance diagnostics: drug delivery devices and lab-on-chip and surgical trainers that support personalized treatment and planning;
• Personalized medicine: implantable printed materials/devices that allowing tissue regeneration or drug delivery management (absorbable or not) and medical devices useful for improving standard medical approaches (i.e., bioprinted surgery devices);
• Zero failure: prosthesis starting from CT or MRI and smart devices capable of reducing errors, rehospitalization via custom rehabilitation, and enabling personalized food and motor activity.

Finally, close attention will be paid to preclinical and clinical studies scalable on animals and humans.

Our objective is to support bioengineers, biologists, and innovation managers in the development of future Industry 5.0 technologies and digital libraries related to bionic and biosynthetic design, underlying the adoption of artificial intelligence within hospitals and healthcare systems.

Prof. Dr. Ruben Foresti
Prof. Dr. Maddalena Botti
Prof. Dr. Fabio Leonardi
Dr. Pasquale D'Angelo
Dr. Roberto Sala
Collection Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the collection website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• 3D bioprinting
• personalized medicine
• therapy continuity
• custom medical devices